|37.92||0||0.00||Vol 35.90K||1Y Perf 7.97%|
|Apr 16th, 2021 10:23 DELAYED|
|-0.11 -0.29%||- -|
|Target Price||38.27||Analyst Rating||Strong Buy 1.33|
|Potential %||1.14||Finscreener Ranking||★★+ 49.10|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||★★★ 52.58|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||★★ 46.26|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||★★+ 43.28|
|Market Cap||22.21B||Earnings Rating||Strong Sell|
|Price Range Ratio 52W %||32.10||Earnings Date||5th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||5th May 2021|
|Estimated EPS Next Report||0.45|
|EPS Growth Next 5 Years %||4.30|
|Avg. Weekly Volume||199.89K|
|Avg. Monthly Volume||267.61K|
|Avg. Quarterly Volume||458.29K|
Fresenius Medical Care AG (NYSE: FMS) stock closed at 37.92 per share at the end of the most recent trading day (a 0.64% change compared to the prior day closing price) with a volume of 245.18K shares and market capitalization of 22.21B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 125364 people. Fresenius Medical Care AG CEO is Rice Powell.
The one-year performance of Fresenius Medical Care AG stock is 7.97%, while year-to-date (YTD) performance is -8.76%. FMS stock has a five-year performance of -13.92%. Its 52-week range is between 33.84 and 46.55, which gives FMS stock a 52-week price range ratio of 32.10%
Fresenius Medical Care AG currently has a PE ratio of 16.00, a price-to-book (PB) ratio of 1.65, a price-to-sale (PS) ratio of 1.40, a price to cashflow ratio of 4.40, a PEG ratio of 2.32, a ROA of 3.59%, a ROC of 6.45% and a ROE of 10.01%. The company’s profit margin is 8.12%, its EBITDA margin is 23.10%, and its revenue ttm is $15.93 Billion , which makes it $27.19 revenue per share.
Of the last four earnings reports from Fresenius Medical Care AG, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.45 for the next earnings report. Fresenius Medical Care AG’s next earnings report date is 05th May 2021.
The consensus rating of Wall Street analysts for Fresenius Medical Care AG is Strong Buy (1.33), with a target price of $38.27, which is +1.14% compared to the current price. The earnings rating for Fresenius Medical Care AG stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Fresenius Medical Care AG has a dividend yield of 1.88% with a dividend per share of $0.72 and a payout ratio of 26.00%.
Fresenius Medical Care AG has a Neutral technical analysis rating based on Technical Indicators (ADX : 10.52, ATR14 : 0.79, CCI20 : 105.80, Chaikin Money Flow : 0.12, MACD : -0.11, Money Flow Index : 72.83, ROC : 1.17, RSI : 46.26, STOCH (14,3) : 81.33, STOCH RSI : 0.89, UO : 55.50, Williams %R : -18.67), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Fresenius Medical Care AG in the last 12-months were:
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.